マイクロ流体免疫測定市場：製品別、技術別、用途別、エンドユーザー別-2030年までの世界予測

マイクロ流体免疫測定市場：製品別（カートリッジ[ポリマー、ガラス、シリコン]、試薬、システム）、技術別（電気化学、光学）、用途別（心臓病学、腫瘍学、感染症）、エンドユーザー別（製薬、病院）-2030年までの世界予測

マイクロ流体イムノアッセイの世界市場は、2023年から2030年までのCAGRが7.4%で、2030年には14億7,000万米ドルに達すると予測されます。

広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、課題、機会の分析から構成されています。この市場の成長を牽引しているのは、創薬・開発およびバイオマーカー検出におけるマイクロ流体イムノアッセイの利用の増加、従来のイムノアッセイに対するラボオンチップイムノアッセイの優位性、製薬・バイオテクノロジー企業による研究開発への注力の高まり、生物学的・化学的アッセイの小型化などです。しかし、マイクロ流体デバイスにおける気泡形成とデッドボリュームがこの市場の成長を抑制しています。

さらに、ポイント・オブ・ケア診断に対する需要の高まりと、マイクロ流体免疫測定技術の最近の進歩は、市場成長の機会を生み出すと期待されています。しかし、マイクロ流体チップの設計に適した基板材料の選択と製品設計、新興諸国におけるコスト関連の制約は、市場利害関係者にとって大きな課題となっています。

本レポートは、製品ポートフォリオの提供、地域的プレゼンス、および業界をリードする市場プレーヤーが数年間（2020-2023年）に採用した主な戦略的発展の広範な評価に基づく競合情勢を提供しています。世界のマイクロ流体イムノアッセイ市場で事業を展開している主要企業は、Becton, Dickinson and Company（米国）、Revvity, Inc.（米国）、Abbott Laboratories（米国）、Siemens Healthineers AG（ドイツ）、Nanomix Corporation（米国）、Micropoint Biotechnologies Co.（中国）、Biosurfit SA（ポルトガル）、Koninklijke Philips N.V.（オランダ）、NanoEnTek Inc.（韓国）、QuidelOrtho Corporation（米国）です。

本レポートで調査した全製品の中で、2023年には消耗品セグメントがマイクロ流体イムノアッセイ市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、キットの反復使用、疾患の早期診断のための疾患特異的キットのポートフォリオの増加、製品認可の増加によるものです。試薬やキットの継続的な進歩、ユーザーフレンドリーな診断キットの開発、臨床ラボや研究ラボでのマイクロ流体免疫測定カートリッジの採用は、マイクロ流体で使用される消耗品の需要にプラスの影響を与えています。

本レポートで調査した技術の中では、電気化学検出分野が予測期間中に最も高いCAGRを記録すると予測されています。電気化学検出は、低コスト・省電力、低サンプル・試薬消費、携帯性、短応答時間などの利点により、マイクロ流体免疫測定でますます使用されるようになっており、このセグメントのCAGRを最も高くする要因となっています。

本レポートで調査したすべてのアプリケーションの中で、2023年には循環器分野がマイクロ流体イムノアッセイ市場で最大のシェアを占めると予想されます。このセグメントの市場シェアが大きいのは、心血管疾患のバイオマーカープロファイリングや疾患メカニズムの解明におけるマイクロ流体カートリッジの用途が増加しているためです。マイクロ流体イムノアッセイの需要は、心臓バイオマーカー研究のための生物医学および臨床分野で増加しており、市場の最大シェアに寄与しています。

本レポートで調査したすべてのエンドユーザーの中で、製薬・バイオテクノロジー企業セグメントは予測期間中に最も高いCAGRで成長すると予測されています。このセグメントのCAGRが最も高いのは、製薬・バイオテクノロジー企業による研究開発投資の増加、創薬研究開発におけるマイクロ流体免疫測定法の普及、個別化医療研究の重視の高まりなどの要因によるものです。製薬企業による研究開発費の増加も、このセグメントの最大シェアに寄与しています。

世界のマイクロ流体イムノアッセイ市場の地域別シナリオの詳細分析では、5つの主要地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）の詳細な定性的・定量的洞察を、各地域の主要国のカバレッジとともに提供しています。2023年には、北米がマイクロ流体イムノアッセイ市場で最大のシェアを占め、次いで欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカが続くと予測されています。北米のシェアが高いのは、医薬品やバイオマーカー同定のための製薬・バイオテクノロジー企業の研究開発費が高いこと、慢性疾患の有病率が高まっていること、ヘルスケア支出が増加していること、同地域に有力な市場プレーヤーが存在すること、研究開発に対する政府のイニシアチブが有利であることなどが背景にあります。米国議会予算局によると、米国の医薬品研究開発費は2020年の911億米ドルから2021年には1,023億米ドルに増加します。

調査範囲：

マイクロ流体免疫測定市場の評価、製品別

• 消耗品
• カートリッジ
  • ポリマー
  • ガラス
  • シリコン
• 試薬
• システム

マイクロ流体免疫測定市場の評価、技術別

• 電気化学検出
• 光学検出

マイクロ流体免疫測定法の市場評価：用途別

• 心臓病学
• 単一バイオマーカー検出
• 多重バイオマーカー検出
• 感染症
• 腫瘍学
• その他のアプリケーション

注：その他のアプリケーションとは、妊娠、糖尿病、甲状腺、腎臓病、乱用薬物検査などです。

マイクロ流体免疫測定市場の評価、エンドユーザー別

• 製薬・バイオテクノロジー企業
• 診断研究所
• 病院
• その他のエンドユーザー

注：その他のエンドユーザーには、在宅ヘルスケア、自己検査、学術機関・研究センター、法医学研究所などが含まれます。

マイクロ流体免疫測定市場アセスメント、地域別

• 北米
• 米国
• カナダ
• 欧州
• ドイツ
• 英国
• フランス
• イタリア
• スペイン
• その他欧州（RoE）
• アジア太平洋（APAC）
• 中国
• 日本
• インド
• その他アジア太平洋地域（RoAPAC）
• ラテンアメリカ
• 中東・アフリカ

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

• 市場
• 概要
• 市場成長への影響要因
  • 市場力学の影響分析
    • 創薬・市場開拓とバイオマーカー検出におけるマイクロ流体免疫測定法の使用の増加が市場成長を促進
    • マイクロ流体デバイスの採用を制限する気泡形成とデッドボリューム
    • ポイントオブケア検査への需要の高まりが市場プレイヤーの成長機会を生み出す
    • マイクロ流体チップの設計に適した基板材料の選択が市場プレイヤーの主要課題であり続ける
  • 要因分析
• 技術動向
  • 多重化パネル検出
  • 紙ベースのマイクロ流体
• 規制分析
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
  • ラテンアメリカ
  • 中東
    • サウジアラビア
• 価格分析
• ポーターのファイブフォース分析

第5章 マイクロ流体イムノアッセイ市場製品別アセスメント

• 概要
• 消耗品
  • カートリッジ
    • ポリマー
    • ガラス
    • シリコン
  • 試薬
• システム

第6章 マイクロ流体免疫測定法の技術別市場評価

• 概要
• 電気化学検出
• 光学検出

第7章 アプリケーション別マイクロ流体免疫測定市場のアプリケーション別評価

• 概要
• 心臓病学
  • 単一バイオマーカー検出
  • 多重バイオマーカー検出
• 感染症
• 腫瘍学
• その他のアプリケーション

第8章 エンドユーザー別マイクロ流体免疫測定市場アセスメント

• 概要
• 製薬・バイオテクノロジー企業
• 診断研究所
• 病院
• その他のエンドユーザー

第9章 マイクロ流体免疫測定市場の地域別アセスメント

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第10章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 差別化要因
  • バンガード
  • 新興企業

第11章 企業プロファイル（企業概要、財務スナップショット、製品ポートフォリオ、戦略的展開）

• Abbott Laboratories
• Revvity, Inc.（Formerly PerkinElmer, Inc.）
• Siemens Healthineers AG.
• QuidelOrtho Corporation.
• Nanomix, Inc.
• Becton, Dickinson and Company
• Micropoint Biotechnologies Co., Ltd.
• Biosurfit SA
• Koninklijke Philips N.V.
• NanoEnTek Inc.

（注：上位5社のSWOT分析を提供します。）

第12章 付録

List of Tables

• Table 1 Funding for Microfluidic Immunoassay Research & Development
• Table 2 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
• Table 3 Research Studies on Paper-Based Microfluidics, 2017-2023
• Table 4 Authorities Regulating In Vitro Diagnostic Products, by Country/Region
• Table 5 Medical Devices Regulatory Authorities in the Rest of APAC Countries
• Table 6 Average Selling Prices of Microfluidic Immunoassay Products (USD/Unit)
• Table 7 Quidelortho Corporation (U.S.): Product Pricing (USD/Unit)
• Table 8 Abbott Laboratories (U.S.): Product Pricing (USD/Unit)
• Table 9 Global Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 10 Global Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 11 Global Microfluidic Immunoassay Consumables Market, by Country/Region, 2021-2030 (USD Million)
• Table 12 Global Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 13 Global Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
• Table 14 Global Polymer-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
• Table 15 Global Glass-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
• Table 16 Global Silicon-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
• Table 17 Global Microfluidic Immunoassay Reagents Market, by Country/Region, 2021-2030 (USD Million)
• Table 18 Global Microfluidic Immunoassay Systems Market, by Country/Region, 2021-2030 (USD Million)
• Table 19 Global Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 20 Global Microfluidic Immunoassay Market for Electrochemical Detection, by Country/Region, 2021-2030 (USD Million)
• Table 21 Optical Detection Techniques for Microfluidic Applications
• Table 22 Global Microfluidic Immunoassay Market for Optical Detection, by Country/Region, 2021-2030 (USD Million)
• Table 23 Global Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 24 Clinically Significant Cardiac Biomarkers
• Table 25 Global Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
• Table 26 Global Microfluidic Immunoassay Market for Cardiology, by Country/Region, 2021-2030 (USD Million)
• Table 27 Commercially Available Tests for Single Cardiac Biomarker Detection
• Table 28 Global Microfluidic Immunoassay Market for Single Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
• Table 29 Commercially Available Tests for Multiplexed Cardiac Biomarker Detection
• Table 30 Global Microfluidic Immunoassay Market for Multiplexed Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
• Table 31 Global Microfluidic Immunoassay Market for Infectious Disease, by Country/Region, 2021-2030 (USD Million)
• Table 32 Clinically Significant Oncology Biomarkers
• Table 33 Global Microfluidic Immunoassay Market for Oncology, by Country/Region, 2021-2030 (USD Million)
• Table 34 Commercially Available Tests for Diabetes Biomarker Detection
• Table 35 Global Microfluidic Immunoassay Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
• Table 36 Global Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 37 Global Microfluidic Immunoassay Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
• Table 38 Global Microfluidic Immunoassay Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
• Table 39 Global Microfluidic Immunoassay Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
• Table 40 Global Microfluidic Immunoassay Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
• Table 41 Global Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
• Table 42 North America: Microfluidic Immunoassay Market, by Country, 2021-2030 (USD Million)
• Table 43 North America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 44 North America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 45 North America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 46 North America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 47 North America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 48 North America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 49 North America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 50 U.S.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 51 U.S.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 52 U.S.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 53 U.S.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 54 U.S.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 55 U.S.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 56 U.S.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 57 Canada: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 58 Canada: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 59 Canada: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 60 Canada: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 61 Canada: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 62 Canada: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 63 Canada: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 64 Europe: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million
• Table 65 Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 66 Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 67 Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 68 Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 69 Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 70 Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 71 Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 72 Germany: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 73 Germany: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 74 Germany: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 75 Germany: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million
• Table 76 Germany: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
• Table 77 Germany: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 78 Germany: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 79 France: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 80 France: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 81 France: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 82 France: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 83 France: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 84 France: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 85 France: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 86 U.K.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 87 U.K.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 88 U.K.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 89 U.K.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 90 U.K.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 91 U.K.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 92 U.K.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 93 Italy: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 94 Italy: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 95 Italy: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 96 Italy: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 97 Italy: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 98 Italy: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 99 Spain: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 100 Spain: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 101 Spain: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 102 Spain: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 103 Spain: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 104 Spain: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 105 Spain: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 106 Covid-19 Cases in European Countries
• Table 107 Rest of Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 108 Rest of Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 109 Rest of Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 110 Rest of Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 111 Rest of Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 112 Rest of Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 113 Rest of Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 114 Asia-Pacific: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
• Table 115 Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 116 Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 117 Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material,2021-2030 (USD Million)
• Table 118 Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 119 Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
• Table 120 Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 121 Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 122 China: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 123 China: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 124 China: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 125 China: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 126 China: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 127 China: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 128 China: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 129 Japan: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 130 Japan: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 131 Japan: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 132 Japan: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 133 Japan: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 134 Japan: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 135 Japan: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 136 India: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 137 India: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 138 India: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 139 India: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 140 India: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 141 India: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 142 India: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 143 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 144 Rest of Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 145 Rest of Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 146 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 147 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 148 Rest of Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
• Table 149 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 150 Latin America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 151 Latin America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 152 Latin America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
• Table 153 Latin America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 154 Latin America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 155 Latin America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 156 Latin America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 157 Saudi Arabia, South Africa, and UAE Estimated Cancer Incidence
• Table 158 Middle East & Africa: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
• Table 159 Middle East & Africa: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
• Table 160 Middle East & Africa: Microfluidic Immunoassay Cartridges Market, by Material, 2021 2030 (USD Million)
• Table 161 Middle East & Africa: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
• Table 162 Middle East & Africa: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
• Table 163 Middle East & Africa: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
• Table 164 Middle East & Africa: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
• Table 165 Recent Developments, by Company, 2020-2023

Microfluidic Immunoassay Market by Product (Cartridge [Polymer, Glass, Silicon], Reagents, System), Technology (Electrochemical, Optical), Application (Cardiology, Oncology, Infectious Disease), and End User (Pharmaceutical, Hospital)-Global Forecast to 2030

The global microfluidic immunoassay market is expected to reach $1.47 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increasing use of microfluidic immunoassays in drug discovery & development and biomarker detection, the advantages of lab-on-chip immunoassays over conventional immunoassays, pharmaceutical & biotechnology companies' increasing focus on research & development, and the miniaturization of biological and chemical assays. However, bubble formation and dead volume in microfluidics devices restrain the growth of this market.

Moreover, the increasing demand for point-of-care diagnostics and recent advancements in microfluidic immunoassay technology are expected to generate market growth opportunities. However, the selection of suitable substrate materials for designing microfluidic chips and product design and cost-related limitations in developing countries are major challenges for market stakeholders.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2023). The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.).

Among all the products studied in this report, in 2023, the consumables segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to the repetitive use of kits, the growing portfolio of disease-specific kits for early diagnosis of diseases, and the increasing product approvals. The continuous advancements in reagents and kits, the development of user-friendly diagnostic kits, and the adoption of microfluidic immunoassay cartridges in clinical and research laboratories are positively impacting the demand for consumables used in microfluidics.

Among all the technologies studied in this report, the electrochemical detection segment is projected to register the highest CAGR during the forecast period. Electrochemical detection is increasingly used in the microfluidic immunoassay owing to benefits such as low cost & power requirements, low sample & reagent consumption, portability, and short response time, contributing to the highest CAGR of this segment.

Among all the applications studied in this report, in 2023, the cardiology segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to increasing applications of microfluidic cartridges in biomarker profiling of cardiovascular diseases and understanding disease mechanisms. The demand for microfluidic immunoassay is increasing in biomedical and clinical fields for research on cardiac biomarkers, contributing to the largest share of the market.

Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to factors such as the increasing R&D investments by pharmaceutical & biotechnology companies, the widespread utilization of microfluidic immunoassay in drug discovery & development, and a growing emphasis on personalized medicine research. The rising spending on R&D by pharmaceutical companies is also contributing to the largest share of this segment.

An in-depth analysis of the geographical scenario of the global microfluidic immunoassay market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the microfluidic immunoassay market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is attributed to the region's high R&D spending by the pharmaceutical & biotechnology companies for the development of drugs and biomarker identification, increasing prevalence of chronic diseases, rising healthcare expenditure, presence of leading market players in the region, and favorable government initiatives for research & development. According to the U.S. Congressional Budget Office, U.S. pharmaceutical R&D expenditure increased from USD 91.1 billion in 2020 to USD 102.3 billion in 2021.

Scope of the Report:

Microfluidic Immunoassay Market Assessment, by Product

• Consumables
• Cartridges
  • Polymer
  • Glass
  • Silicon
• Reagents
• Systems

Microfluidic Immunoassay Market Assessment, by Technology

• Electrochemical Detection
• Optical Detection

Microfluidic Immunoassay Market Assessment, by Application

• Cardiology
• Single Biomarker Detection
• Multiplexed Biomarker Detection
• Infectious Diseases
• Oncology
• Other Applications

Note: Other applications consist of pregnancy, diabetes, thyroid, kidney diseases, and drug of abuse testing

Microfluidic Immunoassay Market Assessment, by End User

• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospital
• Other End Users

Note: Other end users include home healthcare, self-testing, academic institutes & research centers, and forensic labs.

Microfluidic Immunoassay Market Assessment, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of Asia-Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.1.1. Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
    • 4.2.1.2. Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
    • 4.2.1.3. Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
    • 4.2.1.4. Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
  • 4.2.2. Factor Analysis
• 4.3. Technology Trends
  • 4.3.1. Multiplexed Panel Detection
  • 4.3.2. Paper-Based Microfluidics
• 4.4. Regulatory Analysis
  • 4.4.1. North America
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada
  • 4.4.2. Europe
  • 4.4.3. Asia-Pacific
    • 4.4.3.1. China
    • 4.4.3.2. Japan
    • 4.4.3.3. India
  • 4.4.4. Latin America
  • 4.4.5. Middle East
    • 4.4.5.1. Saudi Arabia
• 4.5. Pricing Analysis
• 4.6. Porter's Five Forces Analysis
  • 4.6.1. Bargaining Power of Suppliers
  • 4.6.2. Bargaining Power of Buyers
  • 4.6.3. Threat of Substitutes
  • 4.6.4. Threat of New Entrants
  • 4.6.5. Degree of Competition

5. Microfluidic Immunoassay Market Assessment-by Product

• 5.1. Overview
• 5.2. Consumables
  • 5.2.1. Cartridges
    • 5.2.1.1. Polymer
    • 5.2.1.2. Glass
    • 5.2.1.3. Silicon
  • 5.2.2. Reagents
• 5.3. Systems

6. Microfluidic Immunoassay Market Assessment-by Technology

• 6.1. Overview
• 6.2. Electrochemical Detection
• 6.3. Optical Detection

7. Microfluidic Immunoassay Market Assessment-by Application

• 7.1. Overview
• 7.2. Cardiology
  • 7.2.1. Single Biomarker Detection
  • 7.2.2. Multiplexed Biomarker Detection
• 7.3. Infectious Diseases
• 7.4. Oncology
• 7.5. Other Applications

8. Microfluidic Immunoassay Market Assessment-by End User

• 8.1. Overview
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Diagnostic Laboratories
• 8.4. Hospital
• 8.5. Other End Users

9. Microfluidic Immunoassay Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• 11.1. Abbott Laboratories
• 11.2. Revvity, Inc. (Formerly PerkinElmer, Inc.)
• 11.3. Siemens Healthineers AG.
• 11.4. QuidelOrtho Corporation.
• 11.5. Nanomix, Inc.
• 11.6. Becton, Dickinson and Company
• 11.7. Micropoint Biotechnologies Co., Ltd.
• 11.8. Biosurfit SA
• 11.9. Koninklijke Philips N.V.
• 11.10. NanoEnTek Inc.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports